Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort.
about
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesThe role of HPV in head and neck cancer and review of the HPV vaccineOral human papillomavirus infection and head and neck cancers in HIV-infected individualsOral human papillomavirus detection in older adults who have human immunodeficiency virus infection.Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youthRisk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.HPV-associated Oropharyngeal Cancers--Are They Preventable?High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV InfectionPrevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.The role of human papillomavirus in nongenital cancers.Urban legends series: oral manifestations of HIV infection.Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.Oral prevalence and clearance of oncogenic human papilloma virus in a rehabilitation community for substance abusers in Italy: a case of behavioral correction?HPV oral lesions in HIV-infected patients: the impact of long-term HAART.Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
P2860
Q22306233-0F456E85-F7C4-4E41-8262-D48041448497Q24630128-385E665B-BC8E-4111-879C-1ED5C8918275Q26825257-6CBFB1C9-7BE9-49AA-8E14-7C74345AAB9FQ33570603-6D98CBC4-FBB8-4D60-BF73-51DD94D47A79Q33712114-3609CF61-F530-4BF6-B14A-537D0701B35DQ33947827-CC3F3E80-3FD7-464D-B8C5-3F477BA89982Q35163993-3FEAF598-6E03-436C-8E6F-649BE047E0BCQ35411802-232385F7-2282-42C2-AC3C-006DEFF1310EQ35758895-E4D62362-793B-47A1-9658-EEAB241B4CB2Q35889781-7A66BB85-3B9E-4895-819B-97E90D757FEAQ36208618-8D4E9EBB-79DA-4AD7-89B2-F83A36852618Q37227140-451EA3A2-4870-4355-9A92-A73A31CE9F9AQ37236452-F367E667-C3D9-463C-AD25-129A8D76AECFQ37524405-E372D296-F692-4B44-A988-E972DD72BD98Q38069126-92C8681C-1F47-4B98-AD47-8E72DB51A99EQ38091715-CF5A31F4-CD08-42F6-8183-BAF959D51F16Q38215252-E9C73608-87D9-4978-9E6A-1AFC3B18167EQ40701232-9CD1E264-C513-42BC-9BFC-D05D4FDEBA43Q41658902-3FC27BCE-2CAC-497C-B994-4C5BBCF4B5D0Q46137625-2D2770B7-DE04-47CE-BDD2-A720E8FCB6E4Q58023873-368DC401-8EA2-4DB7-B7F4-91155E457D8A
P2860
Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@ast
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@en
type
label
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@ast
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@en
prefLabel
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@ast
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@en
P2093
P2860
P1433
P1476
Two-week versus six-month samp ...... ion in an HIV-positive cohort.
@en
P2093
Carole Fakhry
Elizabeth Sugar
Maura Gillison
P2860
P304
P356
10.1371/JOURNAL.PONE.0011918
P407
P577
2010-07-30T00:00:00Z